Cargando…

Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines

The global COVID-19 pandemic has led to a race to find medications that can improve the prognosis of the disease. Azithromycin, in association with hydroxychloroquine or chloroquine, has been proposed as one such medication. The aim of this review is to describe the pharmacological mechanism, clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sultana, Janet, Cutroneo, Paola Maria, Crisafulli, Salvatore, Puglisi, Gabriele, Caramori, Gaetano, Trifirò, Gianluca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Current Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371963/ https://www.ncbi.nlm.nih.gov/pubmed/32696429 http://dx.doi.org/10.1007/s40264-020-00976-7

Ejemplares similares

Clinical and economic burden of adverse drug reactions
por: Sultana, Janet, et al.
Publicado: (2013)

Pharmacy Compounding Primer for Physicians: Prescriber Beware
por: Sellers, Sarah, et al.
Publicado: (2012)

Antimicrobial Agents are Societal Drugs: How Should This Influence Prescribing?
por: Sarkar, Paul, et al.
Publicado: (2012)

Frailty and Potentially Inappropriate Prescribing in Older People with Polypharmacy: A Bi-Directional Relationship?
por: Randles, Mary A., et al.
Publicado: (2022)

Pharmacological Management of Borderline Personality Disorder and Common Comorbidities
por: Pascual, Juan C., et al.
Publicado: (2023)

Challenges in the Pharmacologic Management of Obesity and Secondary Dyslipidemia in Children and Adolescents
por: Kennedy, Mary Jayne, et al.
Publicado: (2013)

Limitations of the SCORE-guided European guidelines on cardiovascular disease prevention
por: Mortensen, Martin Bødtker, et al.
Publicado: (2017)

Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent
por: Kristensen, Lars Erik, et al.
Publicado: (2018)

Innovative Approaches for Pharmacology Studies in Pregnant and Lactating Women: A Viewpoint and Lessons from HIV
por: Eke, Ahizechukwu C., et al.
Publicado: (2020)

Intravitreal Anti-VEGF Drugs and Signals of Dementia and Parkinson-Like Events: Analysis of the VigiBase Database of Spontaneous Reports
por: Sultana, Janet, et al.
Publicado: (2020)

Bridging Islands of Information to Establish an Integrated Knowledge Base of Drugs and Health Outcomes of Interest
por: Boyce, Richard D., et al.
Publicado: (2014)

Real-World Evidence: Bridging Gaps in Evidence to Guide Payer Decisions
por: Roberts, Melissa H., et al.
Publicado: (2020)

Clinical Implications of the 2013 ESH/ESC Hypertension Guidelines: Targets, Choice of Therapy, and Blood Pressure Monitoring
por: Kjeldsen, Sverre E., et al.
Publicado: (2014)

NSTE-ACS ESC Guidelines Recommend Prasugrel as the Preferred P2Y12 Inhibitor: A Contrarian View
por: Angoulvant, Denis, et al.
Publicado: (2021)

Treatable Mechanisms in Asthma
por: Cazzola, Mario, et al.
Publicado: (2021)

Pharmacological Therapies of Spinal Muscular Atrophy: A Narrative Review of Preclinical, Clinical–Experimental, and Real-World Evidence
por: Crisafulli, Salvatore, et al.
Publicado: (2023)

Physiologically Based Pharmacokinetic (PBPK) Model-Informed Dosing Guidelines for Pediatric Clinical Care: A Pragmatic Approach for a Special Population
por: Freriksen, Jolien J. M., et al.
Publicado: (2022)

Are the Current Guidelines on Caffeine Use in Sport Optimal for Everyone? Inter-individual Variation in Caffeine Ergogenicity, and a Move Towards Personalised Sports Nutrition
por: Pickering, Craig, et al.
Publicado: (2017)

Confusion: Acetaminophen Dosing Changes Based on NO Evidence in Adults
por: Krenzelok, Edward P., et al.
Publicado: (2012)

Pain in Intellectually Disabled Children: Towards Evidence-Based Pharmacotherapy?
por: Valkenburg, Abraham J., et al.
Publicado: (2015)

Assumption versus evidence: the case of digoxin in atrial fibrillation and heart failure
por: Bavendiek, Udo, et al.
Publicado: (2017)

Review of evidence on using ACEi and ARBs in patients with hypertension and COVID-19
por: Khan, Sikandar Hayat, et al.
Publicado: (2020)

Personalized, Evidence-Informed Training Plans and Exercise Prescriptions for Performance, Fitness and Health
por: Wackerhage, Henning, et al.
Publicado: (2021)

Policy Options for Infliximab Biosimilars in Inflammatory Bowel Disease Given Emerging Evidence for Switching
por: Husereau, Don, et al.
Publicado: (2018)

Future Evolution of Biosimilar Development by Application of Current Science and Available Evidence: The Developer’s Perspective
por: Cohen, Hillel P., et al.
Publicado: (2023)

Evidence-Based Medicine and Healthcare Quality in the Context of Information Failure: The Case of the UK Fertility Sector
por: Zhu, Minyan
Publicado: (2021)

Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence
por: Facente, Shelley N., et al.
Publicado: (2021)

Promise of Real-World Evidence for Patient Centricity in Gulf Cooperation Council Countries: Call to Action
por: Farghaly, Mohamed Nasr Mahmoud Hassan, et al.
Publicado: (2022)

Antipsychotic-Induced Metabolic and Cardiovascular Side Effects in Schizophrenia: A Novel Mechanistic Hypothesis
por: Scigliano, Giulio, et al.
Publicado: (2013)

Different Weights of the Evidence-Based Medicine Triad in Regulatory, Health Technology Assessment, and Clinical Decision Making
por: Schlegl, Evelyn, et al.
Publicado: (2017)

Cell Therapy of Severe Ischemia in People with Diabetic Foot Ulcers—Do We Have Enough Evidence?
por: Dubský, Michal, et al.
Publicado: (2023)

Beyond COVID-19 deaths during the COVID-19 pandemic in the United States
por: Jacobson, Sheldon H., et al.
Publicado: (2021)

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
por: Chapman, M. John, et al.
Publicado: (2011)

Economic Evaluation Evidence for Resource-Allocation Decision Making: Bridging the Gap for Local Decision Makers Using English Case Studies
por: Howdon, Daniel, et al.
Publicado: (2022)

Differential epigenetic factors in the prediction of cardiovascular risk in diabetic patients
por: Napoli, Claudio, et al.
Publicado: (2020)

Excess deaths by sex and Age Group in the first two years of the COVID-19 pandemic in the United States
por: Ludden, Ian G., et al.
Publicado: (2022)

Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis
por: Crisafulli, Salvatore, et al.
Publicado: (2020)

Challenges for Drug Repurposing in the COVID-19 Pandemic Era
por: Sultana, Janet, et al.
Publicado: (2020)

Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma?
por: Cazzola, Mario, et al.
Publicado: (2023)

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
por: Ference, Brian A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jeiatakanfch0070s4fpg83rhg